Cite
MLA Citation
Jacobus Pfisterer et al.. “Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.” Lancet oncology, vol. 21, no. 5, 2020, pp. 699–709. http://access.bl.uk/ark:/81055/vdc_100104116707.0x000015